Investment Summary

Pemba Capital Partners Invests In Arteva Funding

On August 20, 2021, private equity firm Pemba Capital Partners invested in financial services company Arteva Funding

Investment Highlights
  • This is Pemba Capital Partners’ 2nd transaction in the Financial Services sector.
  • This is Pemba Capital Partners’ 28th transaction in Australia.

Investment Summary
Date 2021-08-20
Target Arteva Funding
Sector Financial Services
Investor(s) Pemba Capital Partners
Deal Type Growth Capital

Target

Arteva Funding

Norwood, Australia
Arteva Funding is an independent insurance funding company, Arteva provides finance and payment solutions that have purpose, are easy to access and break the mould of other solutions out there. Arteva Funding is based in Norwood, Australia.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Pemba Capital Partners

Sydney, Australia

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1998
PE ASSETS 2.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Pemba Capital Partners is an independent private equity firm backed by the FirstRand Group focused on public and private company investments in Australia and New Zealand. Pemba looks to invest in profitable companies valued from $30 to $150 million AU. Pemba is a generalist investor, looking for opportunities in a variety of industries positioned for organic growth or growth through acquisitions. Pemba will not invest include early-stage or pure technology, hostile takeovers, property or construction, infrastructure, and agriculture or resources. Pemba Capital Partners was formed in 1998 and is based in Sydney, Australia.

DEAL STATS #
Overall 32 of 43
Sector (Financial Services) 2 of 3
Type (Growth Capital) 5 of 11
Country (Australia) 28 of 39
Year (2021) 3 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-01 RxPx

Sydney, Australia

RxPx provides digital risk management and patient adherence SaaS solutions in the specialty medicine sector, predominately in the Multiple Sclerosis (MS) market. It is focused on the commercialisation stage of the drug life cycle, assisting pharmaceutical companies on the launch and global roll out of new and in-market approved drugs. RxPx was founded in 2013 and is based in Sydney, Australia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-13 Vets Central

Bundall , Australia

Vets Central offers support to veterinary practitioners via a dedicated head office (with recruitment, finance, marketing, procurement, etc), freeing up vets to practice on what matters – patient care & medicine. Vets Central is based in Bundall, Australia.

Buy -
Mergr

Product

Company

Legal